FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385346050> ?p ?o ?g. }

• W4385346050 endingPage "234" @default.
• W4385346050 startingPage "228" @default.
• W4385346050 abstract "Heparin is the most widely used anticoagulant for cardiopulmonary bypass (CPB). Several authors suggest that lower doses of heparin during CPB would produce lower postoperative chest tube losses and fewer transfusion events. In the present study, a heparin dose–response (HDR) test was used to determine the heparin dose for each patient. We hypothesize that higher doses of heparin do not cause increased postoperative bleeding and transfusion events in postoperative patients undergoing CPB when the heparin dose is determined by a HDR test. This prospective observational study followed 66 patients undergoing CPB-supported primary coronary artery bypass grafting. Patients were placed in one of two groups, sensitive (n = 37) or resistant (n = 29) based on the result of a HDR test slope. Data on patient characteristics, secondary outcomes, transfusion, and the primary outcome, chest tube losses, were collected. Patient characteristics differed in the baseline activated coagulation time (ACT) and thromboelastograph G parameter as well as number of patients with hypercholesterolemia. The resistant group had lower postheparin and postprotamine ACTs and heparin sensitivity index. Initial heparin dose, total heparin dose, heparin dose per kilogram, HDR, and protamine dose were higher in the heparin-resistant group. The primary outcome, postoperative chest tube loss volume, was collected at four time points and the two groups were then compared. The heparin-resistant group was noninferior to the sensitive group and had clinically fewer transfused patients and transfusion events. The resistant group was noninferior to the sensitive group with respect to chest tube losses at all measured time points. Higher doses of heparin determined by a HDR test do not cause increased postoperative chest tube losses or increased transfusion events." @default.
• W4385346050 created "2023-07-29" @default.
• W4385346050 creator A5026759719 @default.
• W4385346050 creator A5050547972 @default.
• W4385346050 date "2013-12-01" @default.
• W4385346050 modified "2023-09-30" @default.
• W4385346050 title "Heparin Dose and Postoperative Bleeding in Patients Undergoing Cardiopulmonary Bypass" @default.
• W4385346050 cites W145449876 @default.
• W4385346050 cites W1600059517 @default.
• W4385346050 cites W1989560973 @default.
• W4385346050 cites W2002294861 @default.
• W4385346050 cites W2052113322 @default.
• W4385346050 cites W2073452994 @default.
• W4385346050 cites W2097485631 @default.
• W4385346050 cites W2163005726 @default.
• W4385346050 cites W2164300843 @default.
• W4385346050 cites W2921624683 @default.
• W4385346050 doi "https://doi.org/10.1051/ject/201345228" @default.
• W4385346050 hasPublicationYear "2013" @default.
• W4385346050 type Work @default.
• W4385346050 citedByCount "2" @default.
• W4385346050 countsByYear W43853460502017 @default.
• W4385346050 countsByYear W43853460502018 @default.
• W4385346050 crossrefType "journal-article" @default.
• W4385346050 hasAuthorship W4385346050A5026759719 @default.
• W4385346050 hasAuthorship W4385346050A5050547972 @default.
• W4385346050 hasBestOaLocation W43853460501 @default.
• W4385346050 hasConcept C141071460 @default.
• W4385346050 hasConcept C2777063151 @default.
• W4385346050 hasConcept C2777557582 @default.
• W4385346050 hasConcept C2777987278 @default.
• W4385346050 hasConcept C2778205648 @default.
• W4385346050 hasConcept C2778329176 @default.
• W4385346050 hasConcept C2778881276 @default.
• W4385346050 hasConcept C2780835560 @default.
• W4385346050 hasConcept C42219234 @default.
• W4385346050 hasConcept C71924100 @default.
• W4385346050 hasConceptScore W4385346050C141071460 @default.
• W4385346050 hasConceptScore W4385346050C2777063151 @default.
• W4385346050 hasConceptScore W4385346050C2777557582 @default.
• W4385346050 hasConceptScore W4385346050C2777987278 @default.
• W4385346050 hasConceptScore W4385346050C2778205648 @default.
• W4385346050 hasConceptScore W4385346050C2778329176 @default.
• W4385346050 hasConceptScore W4385346050C2778881276 @default.
• W4385346050 hasConceptScore W4385346050C2780835560 @default.
• W4385346050 hasConceptScore W4385346050C42219234 @default.
• W4385346050 hasConceptScore W4385346050C71924100 @default.
• W4385346050 hasIssue "4" @default.
• W4385346050 hasLocation W43853460501 @default.
• W4385346050 hasOpenAccess W4385346050 @default.
• W4385346050 hasPrimaryLocation W43853460501 @default.
• W4385346050 hasRelatedWork W2003963773 @default.
• W4385346050 hasRelatedWork W2004641063 @default.
• W4385346050 hasRelatedWork W2060764498 @default.
• W4385346050 hasRelatedWork W206436102 @default.
• W4385346050 hasRelatedWork W2079160576 @default.
• W4385346050 hasRelatedWork W2333224211 @default.
• W4385346050 hasRelatedWork W2395065705 @default.
• W4385346050 hasRelatedWork W2416007221 @default.
• W4385346050 hasRelatedWork W4233413356 @default.
• W4385346050 hasRelatedWork W4385346050 @default.
• W4385346050 hasVolume "45" @default.
• W4385346050 isParatext "false" @default.
• W4385346050 isRetracted "false" @default.
• W4385346050 workType "article" @default.